Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro

Molecular Vision

Volumn 18, Issue , 2012, Pages 851-863

  Clouzeau, Chloé ^a,b,c,f   Godefroy, David ^a,b,c   Riancho, Luisa ^a,b,c   Rostène, William ^a,b,c   Baudouin, Christophe ^a,b,c,d,e   Brignole Baudouin, Françoise ^a,b,c,d,f  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

^d CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; BENZALKONIUM CHLORIDE; CASPASE 3; CYTOCHROME C; EYE DROPS; PHALLOIDIN; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SUPEROXIDE;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL CULTURE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CELL VIABILITY; CHROMATIN CONDENSATION; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; DRUG CYTOTOXICITY; DRY EYE; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYPEROSMOLARITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYSOSOME; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; OXIDATIVE STRESS; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN TRANSPORT; SPECTROFLUOROMETRY; TEAR FILM;

APOPTOSIS; APOPTOSIS INDUCING FACTOR; BENZALKONIUM COMPOUNDS; CASPASE 3; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHROMATIN; CONJUNCTIVA; CYTOCHROMES C; EPITHELIAL CELLS; HUMANS; MICROSCOPY, PHASE-CONTRAST; MITOCHONDRIA; OPHTHALMIC SOLUTIONS; OSMOLAR CONCENTRATION; OXIDATIVE STRESS; PRESERVATIVES, PHARMACEUTICAL; SODIUM CHLORIDE; XEROPHTHALMIA;

EID: 84860850886     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5:75-92. misctextPMID: 17508116/misctext
2. Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, Feuer W, Reis BL. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998; 17:38-56. [PMID: 9436879]
3. Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol 2002; 133:181-6. [PMID: 11812420]
4. Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007; 143:409-15. [PMID: 17317388]
5. Baudouin C. A new approach for better comprehension of diseases of the ocular surface. J Fr Ophtalmol 2007; 30:239-46. [PMID: 17417148]
6. Barabino S, Dana MR. Animal models of dry eye: a critical assessment of opportunities and limitations. Invest Ophthalmol Vis Sci 2004; 45:1641-6. [PMID: 15161821]
7. Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci 2003; 44:124-9. [PMID: 12506064]
8. Pflugfelder SC, Farley W, Luo L, Chen LZ, De Paiva CS, Olmos LC, Li DQ, Fini ME. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 2005; 166:61-71. [PMID: 15632000]
9. van Blokland SC, Versnel MA. Pathogenesis of Sjogren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin Immunol 2002; 103:111-24. [PMID: 12027416]
10. Toshida H, Nguyen DH, Beuerman RW, Murakami A. Evaluation of novel dry eye model: preganglionic parasympathetic denervation in rabbit. Invest Ophthalmol Vis Sci 2007; 48:4468-75. [PMID: 17898267]
11. Gilbard JP, Rossi SR, Heyda KG. Tear film and ocular surface changes after closure of the meibomian gland orifices in the rabbit. Ophthalmology 1989; 96:1180-6. [PMID: 2797721]
12. Gilbard JP, Rossi SR, Gray KL, Hanninen LA. Natural history of disease in a rabbit model for keratoconjunctivitis sicca. Acta Ophthalmol Suppl 1989; 192:95-101. [PMID: 2554662]
13. Fujihara T, Murakami T, Fujita H, Nakamura M, Nakata K. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci 2001; 42:96-100. [PMID: 11133853]
14. Coassin M, Lambiase A, Costa N, De Gregorio A, Sgrulletta R, Sacchetti M, Aloe L, Bonini S. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. Graefes Arch Clin Exp Ophthalmol 2005; 243:151-5. [PMID: 15650854]
15. Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci 2005; 46:2766-71. [PMID: 16043849]
16. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 2001; 73:449-59. [PMID: 11825017]
17. Li DQ, Chen Z, Song XJ, Luo L, Pflugfelder SC. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2004; 45:4302-11. [PMID: 15557436]
18. Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res 2006; 82:588-96. [PMID: 16202406]
19. Narayanan S, Manning J, Proske R, McDermott AM. Effect of hyperosmolality on beta-defensin gene expression by human corneal epithelial cells. Cornea 2006; 25:1063-8. [PMID: 17133055]
20. Chen Z, Tong L, Li Z, Yoon KC, Qi H, Farley W, Li DQ, Pflugfelder SC. Hyperosmolarity-induced cornification of human corneal epithelial cells is regulated by JNK MAPK. Invest Ophthalmol Vis Sci 2008; 49:539-49. [PMID: 18234997]
21. Bildin VN, Wang Z, Iserovich P, Reinach PS. Hypertonicityinduced p38MAPK activation elicits recovery of corneal epithelial cell volume and layer integrity. J Membr Biol 2003; 193:1-13. [PMID: 12879161]
22. Capó-Aponte JE, Wang Z, Bildin VN, Pokorny KS, Reinach PS. Fate of hypertonicity-stressed corneal epithelial cells depends on differential MAPK activation and p38MAPK/Na-K-2Cl cotransporter1 interaction. Exp Eye Res 2007; 84:361-72. [PMID: 17140565]
23. Pan Z, Wang Z, Yang H, Zhang F, Reinach PS. TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2011; 52:485-93. [PMID: 20739465]
24. Png E, Samivelu GK, Yeo SH, Chew J, Chaurasia SS, Tong L. Hyperosmolarity mediated mitochondrial dysfunction requires transglutaminase-2 in human corneal epithelial cells. J Cell Physiol 2011; 226:693-9. [PMID: 20717931]
25. Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea 2007; 26:452-60. [PMID: 17457195]
26. Xiong C, Chen D, Liu J, Liu B, Li N, Zhou Y, Liang X, Ma P, Ye C, Ge J, Wang Z. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci 2008; 49:1850-6. [PMID: 18436819]
27. Lin Z, Liu X, Zhou T, Wang Y, Bai L, He H, Liu Z. A mouse dry eye model induced by topical administration of benzalkonium chloride. Mol Vis 2011; 17:257-64. [PMID: 21283525]
28. Debbasch C, Brignole F, Pisella PJ, Warnet JM, Rat P, Baudouin C. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001; 42:642-52. [PMID: 11222522]
29. Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci 2005; 46:4594-9. [PMID: 16303954]
30. Liang H, Baudouin C, Pauly A, Brignole-Baudouin F. Conjunctival and corneal reactions in rabbits following shortand repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol 2008; 92:1275-82. [PMID: 18723745]
31. Pauly A, Meloni M, Brignole-Baudouin F, Warnet JM, Baudouin C. Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. Invest Ophthalmol Vis Sci 2009; 50:1644-52. [PMID: 19168896]
32. Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol 1996; 7:80-6. [PMID:10163327]
33. Rolando M, Terragna F, Giordano G, Calabria G. Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study. Ophthalmologica 1990; 200:170-6. [PMID: 2367078]
34. Kahook MY, Noecker R. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Adv Ther 2008; 25:743-51. [PMID: 18670744]
35. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008; 17:350-5. [PMID: 18703943]
36. Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010; 29:312-34. [PMID: 20302969]
37. Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002; 86:418-23. [PMID: 11914211]
38. Jaenen N, Baudouin C, Pouliquen P, Manni G, Figueiredo A, Zeyen T. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 2007; 17:341-9. [PMID: 17534814]
39. Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 2010; 29:618-21. [PMID: 20386433]
40. Erb C, Gast U, Schremmer D. German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol 2008; 246:1593-601. [PMID: 18648841]
41. Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol 2008; 86:716-26. [PMID: 18537937]
42. Labbé A, Terry O, Brasnu E, Van Went C, Baudouin C. Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Cornea. In press
43. Brasnu E, Brignole-Baudouin F, Riancho L, Warnet JM, Baudouin C. Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines. Mol Vis 2008; 14:394-402. [PMID: 18334956]
44. Di Virgilio F. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today 1995; 16:524-8. [PMID: 7495489]
45. Gilbard JP, Farris RL, Santamaria J 2nd. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol 1978; 96:677-81. [PMID: 646697]
46. Lemp MA, Bron AJ, Baudouin C, Benitez Del Castillo JM, Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011; 151:792-8. [PMID: 21310379]
47. Bildin VN, Yang H, Crook RB, Fischbarg J, Reinach PS. Adaptation by corneal epithelial cells to chronic hypertonic stress depends on upregulation of Na:K:2Cl cotransporter gene and protein expression and ion transport activity. J Membr Biol 2000; 177:41-50. [PMID: 10960152]
48. Brasnu E, Brignole-Baudouin F, Riancho L, Guenoun JM, Warnet JM, Baudouin C. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line. Curr Eye Res 2008; 33:303-12. [PMID: 18398704]
49. Reinehr R, Häussinger D. Hyperosmotic activation of the CD95 system. Methods Enzymol 2007;428:145-60. [PMID: 17875416]
50. St-Louis R, Parmentier C, Raison D, Grange-Messent V, Hardin-Pouzet H. Reactive oxygen species are required for the hypothalamic osmoregulatory response. Endocrinology 2012; 153:1317-29. [PMID: 22202167]
51. De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G, Baudouin C. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999; 40:619-30. [PMID: 10067965]
52. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397:441-6. [PMID: 9989411]
53. Lorenzo HK, Susin SA, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 1999; 6:516-24. [PMID: 10381654]
54. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998; 17:584-9. [PMID: 9820935]
55. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. A unified theory of the role of the ocular surface in dry eye. Adv Exp Med Biol 1998; 438:643-51. [PMID: 9634949]
56. Pflugfelder SC, Solomon A, Stern M. The diagnosis and management of dry eye: a twenty-five-year review. Cornea 2000; 19:644-9. [PMID: 11009316]
57. Barabino S, Dana MR. Dry eye syndromes. Chem Immunol Allergy 2007; 92:176-84. [PMID: 17264493]
58. Paulsen K, Maile S, Giebel J, Tost FH. Lubricating agents differ in their protection of cultured human epithelial cells against desiccation. Med Sci Monit 2008; 14:PI12-6. [PMID: 18509283]
59. Versura P, Profazio V, Schiavi C, Campos EC. Hyperosmolar Stress Upregulates HLA-DR Expression in Human Conjunctival Epithelium in Dry Eye Patients and In Vitro Models. Invest Ophthalmol Vis Sci 2011; 52:5488-96. [PMID: 21498621]
60. Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjogren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci 1994; 35:3493-504. [PMID: 8056525]
61. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells in patients with dry eyes. Invest Ophthalmol Vis Sci 2000; 41:1356-63. [PMID: 10798650]
62. Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporine A. Invest Ophthalmol Vis Sci 2001; 42:90-5. [PMID: 11133852]